Call our 24 hours, seven days a week helpline at 800.272.3900

24/7 Helpline 800.272.3900
Donate

 

Families Facing Alzheimer’s Need Your Support

Families Facing Alzheimer’s Need Your Support

We're leading the way toward ending Alzheimer's and all other dementia. Donate today so we can continue accelerating vital research and providing 24/7 support to families who depend on it.

Give Now
Alzheimer’s Disease Doesn’t Stop. Neither Do We.

Federal Alzheimer's and Dementia Research Funding Signed Into Law

Federal Alzheimer's and Dementia Research Funding Signed Into Law
Share or Print this page
Share or Print this page
December 20, 2019
Email: media@alz.org
Share or Print this page
Annual National Institutes of Health Funding for Alzheimer’s and Dementia Research Reaches $2.8 Billion
 
WASHINGTON, D.C., December 20, 2019 — The Alzheimer’s Association and Alzheimer’s Impact Movement (AIM) are deeply grateful for the bipartisan support and leadership resulting in a $350 million increase for Alzheimer’s and dementia research funding at the National Institutes of Health (NIH) signed into law today. Additionally the inclusion of $10 million to implement the BOLD Infrastructure for Alzheimer’s Act (P.L. 115-406) is an important step toward acknowledging and addressing Alzheimer’s as a widespread public health crisis.
 
Since the passage of the National Alzheimer's Project Act (NAPA) and the Alzheimer's Accountability Act — two laws championed by the Alzheimer's Association and AIM — Congressional leaders have made addressing Alzheimer's a priority. Since the passage of NAPA, Congress has expanded access to care and support services and increased Alzheimer’s and dementia research funding more than six-fold.
 
“These funds are laying the groundwork for much-needed breakthroughs that will help all those affected by this devastating disease,” said Robert Egge, Alzheimer’s Association chief public policy officer and AIM executive director. “We are thankful for our dedicated advocates who have passionately driven Congress to act, and for our bipartisan Congressional champions who understand the importance of medical and NIH-driven research,” continued Egge.
 
Longtime Congressional champions including Sen. Roy Blunt (R-Mo.), Sen. Patty Murray (D-Wash.), Rep. Rosa DeLauro (D-Conn.) and Rep. Tom Cole (R-Okla.) have been instrumental in securing historic increases.
 
The most expensive disease in the country, costing taxpayers $290 billion in 2019, more than 5 million Americans are living with the disease and an estimated 16 million more are providing unpaid care. We owe it to these individuals and the millions more who will be impacted in the coming years to leave no stone unturned so we can advance treatments and find a cure for this devastating disease.
 

Alzheimer's Association

The Alzheimer's Association is the leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. For more information, visit www.alz.org.

Alzheimer’s Impact Movement

The Alzheimer's Impact Movement (AIM) is a separately incorporated advocacy affiliate of the Alzheimer's Association. AIM advances and develops policies to overcome Alzheimer's disease through increased investment in research, enhanced care and improved support. For more information, visit alzimpact.org.
 

Keep Up With Alzheimer’s News and Events